Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q27024502)
Watch
English
Immune escape mechanisms as a guide for cancer immunotherapy
scientific article
In more languages
edit
Statements
instance of
scholarly article
2 references
stated in
PubMed
stated in
Europe PubMed Central
PMC publication ID
4334715
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25501578%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 February 2020
review article
1 reference
stated in
Europe PubMed Central
title
Immune escape mechanisms as a guide for cancer immunotherapy
(English)
1 reference
stated in
Europe PubMed Central
PMC publication ID
4334715
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25501578%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 February 2020
main subject
immunotherapy
1 reference
based on heuristic
inferred from title
evasion of host immune response
1 reference
based on heuristic
inferred from title
author
Gregory L Beatty
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
4334715
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25501578%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 February 2020
author name string
Whitney L Gladney
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMC publication ID
4334715
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25501578%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 February 2020
language of work or name
English
1 reference
stated in
PubMed
publication date
12 December 2014
1 reference
stated in
Europe PubMed Central
PMC publication ID
4334715
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25501578%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 February 2020
published in
Clinical Cancer Research
2 references
stated in
PubMed
stated in
Europe PubMed Central
PMC publication ID
4334715
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25501578%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 February 2020
volume
21
2 references
stated in
PubMed
stated in
Europe PubMed Central
PMC publication ID
4334715
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25501578%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 February 2020
issue
4
2 references
stated in
PubMed
stated in
Europe PubMed Central
PMC publication ID
4334715
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25501578%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 February 2020
page(s)
687-692
1 reference
stated in
Europe PubMed Central
PMC publication ID
4334715
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25501578%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 February 2020
cites work
Innate and adaptive immune cells in the tumor microenvironment
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334715
retrieved
21 March 2017
The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334715
retrieved
21 March 2017
Cancer genome landscapes
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334715
retrieved
21 March 2017
Neutralizing tumor-promoting chronic inflammation: a magic bullet?
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334715
retrieved
21 March 2017
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334715
retrieved
21 March 2017
Nivolumab plus ipilimumab in advanced melanoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334715
retrieved
21 March 2017
Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334715
retrieved
21 March 2017
The blockade of immune checkpoints in cancer immunotherapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334715
retrieved
21 March 2017
Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334715
retrieved
21 March 2017
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334715
retrieved
21 March 2017
Genetic basis for clinical response to CTLA-4 blockade in melanoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334715
retrieved
7 April 2017
Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334715
retrieved
7 April 2017
Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334715
retrieved
7 April 2017
Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334715
retrieved
7 April 2017
Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacy.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334715
retrieved
28 September 2017
VISTA Regulates the Development of Protective Antitumor Immunity
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334715
retrieved
28 September 2017
HLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic marker
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334715
retrieved
28 September 2017
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334715
retrieved
28 September 2017
Safety, efficacy, and biomarkers of nivolumab with vaccine in ipilimumab-refractory or -naive melanoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334715
retrieved
28 September 2017
Evaluation of ipilimumab in combination with allogeneic pancreatic tumor cells transfected with a GM-CSF gene in previously treated pancreatic cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334715
retrieved
28 September 2017
Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334715
retrieved
28 September 2017
Oncology meets immunology: the cancer-immunity cycle
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334715
retrieved
28 September 2017
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334715
retrieved
28 September 2017
Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334715
retrieved
28 September 2017
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334715
retrieved
28 September 2017
Monocytic CCR2(+) myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334715
retrieved
28 September 2017
Selection of CD8+PD-1+ lymphocytes in fresh human melanomas enriches for tumor-reactive T cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334715
retrieved
28 September 2017
Dual roles for immunity in gastrointestinal cancers
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334715
retrieved
28 September 2017
Human leukocyte antigen class I expression is an independent prognostic factor in advanced ovarian cancer resistant to first-line platinum chemotherapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334715
retrieved
28 September 2017
HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334715
retrieved
28 September 2017
Creating immune privilege: active local suppression that benefits friends, but protects foes.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334715
retrieved
28 September 2017
Effector memory T cells, early metastasis, and survival in colorectal cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334715
retrieved
28 September 2017
Classical and nonclassical HLA class I antigen and NK Cell-activating ligand changes in malignant cells: current challenges and future directions
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334715
retrieved
28 September 2017
Deficiency of transporter for antigen presentation (TAP) in tumor cells allows evasion of immune surveillance and increases tumorigenesis.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334715
retrieved
28 September 2017
Natural history of HLA expression during tumour development.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334715
retrieved
28 September 2017
On immunosurveillance in human cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334715
retrieved
28 September 2017
The concept of immunological surveillance
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334715
retrieved
28 September 2017
Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334715
retrieved
31 May 2018
A mechanistic theory to explain the efficacy of antiretroviral therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334715
retrieved
28 November 2018
Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334715
retrieved
28 November 2018
Tumor exome analysis reveals neoantigen-specific T-cell reactivity in an ipilimumab-responsive melanoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334715
retrieved
28 November 2018
Effect of human leukocyte antigen class I expression of tumor cells on outcome of intravesical instillation of bacillus calmette-guerin immunotherapy for bladder cancer
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/25501578
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1158/1078-0432.CCR-14-1860
2 references
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
2855394
stated in
Europe PubMed Central
PMC publication ID
4334715
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25501578%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 February 2020
OpenCitations bibliographic resource ID
2855394
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
2855394
PMC publication ID
4334715
2 references
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
2855394
stated in
Europe PubMed Central
PMC publication ID
4334715
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25501578%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 February 2020
PubMed publication ID
25501578
2 references
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
2855394
stated in
Europe PubMed Central
PMC publication ID
4334715
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25501578%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 February 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
